(EVLO) |
0 (0%)
|
09-28 21:13 |
Open: |
|
Pre. Close: |
|
High:
|
|
Low:
|
|
Volume:
|
0 |
Market Cap:
|
0(M) |
|
|
Technical analysis |
as of: 2023-09-28 4:50:23 PM |
Short-term rate:
|
|
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
Mid-term rate:
|
|
Target: |
Six months: 7.14 One year: 8.98 |
Support: |
Support1: 3.56 Support2: 2.97 |
Resistance: |
Resistance1: 6.11 Resistance2: 7.68 |
Pivot: |
4.99  |
Moving Average: |
MA(5): 3.96 MA(20): 5.33 
MA(100): 5.32 MA(250): 16.41  |
MACD: |
MACD(12,26): -1 Signal(9): -0.9  |
Stochastic oscillator: |
%K(14,3): 12.8 %D(3): 9.1  |
RSI: |
RSI(14): 34.8  |
52-week: |
High: 48.4 Low: 0.47 |
Average Vol(K): |
3-Month: 605 (K) 10-Days: 107 (K) |
|
Price, moving averages and Bollinger Bands |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ EVLO ] has closed above bottom band by 25.7%. Bollinger Bands are 8.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
4.28 - 4.31 |
4.31 - 4.33 |
Low:
|
3.8 - 3.82 |
3.82 - 3.84 |
Close:
|
3.96 - 4 |
4 - 4.04 |
|
Company Description |
|
Headline News |
Wed, 27 Sep 2023 Is Evelo Biosciences Inc (EVLO) a Smart Choice in Biotechnology Wednesday? - InvestorsObserver
Thu, 07 Sep 2023 Evelo Biosciences Target of Unusually High Options Trading ... - MarketBeat
Fri, 25 Aug 2023 Healthcare Stocks Moving Friday: YS, EVLO, BNOX, PGEN, CLVR, TIVC, BJDX, ONVO - InvestorsObserver
Fri, 25 Aug 2023 Evelo Biosciences Inc (EVLO) Stock Loses -14.31% This Week; Should You Buy? - InvestorsObserver
Fri, 18 Aug 2023 Healthcare Stocks on the Move Friday: VAPO, CHEK, AGEN, FBIOP, EVLO, CARM, THTX, NNOX - InvestorsObserver
Thu, 10 Aug 2023 How Does Evelo Biosciences Inc (EVLO) Stock Rank on Wall Street Thursday? - InvestorsObserver
|
Financial Analysis |
Price to Book Value: |
Neutral |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Price to Earnings: |
Neutral |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Discounted cash flow: |
Neutral |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Return on Assets: |
Neutral |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Return on Equity: |
Neutral |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Debt to Equity: |
Neutral |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: |
Sector: |
Industry: |
Shares Out. |
19 (M) |
Shares Float |
7 (M) |
% Held by Insiders
|
0 (%) |
% Held by Institutions
|
76.7 (%) |
Shares Short
|
278 (K) |
Shares Short P.Month
|
457 (K) |
Stock Financials |
EPS
|
-13.85 |
EPS Est Next Qtl
|
0 |
EPS Est This Year
|
0 |
EPS Est Next Year
|
0 |
Book Value (p.s.)
|
-8.24 |
Profit Margin (%)
|
0 |
Operating Margin (%)
|
0 |
Return on Assets (ttm)
|
-84.7 |
Return on Equity (ttm)
|
0 |
Qtrly Rev. Growth
|
0 |
Gross Profit (p.s.)
|
0 |
Sales Per Share
|
0 |
EBITDA (p.s.)
|
-4.68 |
Qtrly Earnings Growth
|
0 |
Operating Cash Flow
|
-86 (M) |
Levered Free Cash Flow
|
-49 (M) |
Stock Valuations |
PE Ratio
|
-0.29 |
PEG Ratio
|
0 |
Price to Book value
|
-0.49 |
Price to Sales
|
0 |
Price to Cash Flow
|
-0.88 |
Stock Dividends |
Dividend
|
0 |
Forward Dividend
|
0 |
Dividend Yield
|
0% |
Dividend Pay Date
|
Invalid DateTime. |
Ex-Dividend Date
|
Invalid DateTime. |
Your Ad Here
|
|